Pure red cell aplasia developing into myeloproliferation with myelodysplasia and subsequent leukemia after cyclosporin A therapy

scientific article published in June 2002

Pure red cell aplasia developing into myeloproliferation with myelodysplasia and subsequent leukemia after cyclosporin A therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/BF02982116
P698PubMed publication ID12095153

P2093author name stringTaro Yamashita
Takanori Ueda
Shin Imamura
Takahiro Yamauchi
Hiroshi Tsutani
Atsushi Kuwata
Haruhisa Shirasaki
P2860cites work[Successful immunosuppressive therapy for a patient with hypoplastic myelodysplastic syndrome]Q73191203
Immunosuppressive therapy for hypoplastic myelodysplastic syndromeQ73265771
Association between trisomy 8 and the immunophenotype of blast cells from acute leukemias secondary to a myelodysplastic syndrome or chronic myeloproliferative disordersQ73454174
Prolonged response to cyclosporin-A in hypoplastic refractory anemia and correlation with in vitro studiesQ73463287
Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrowQ74263466
Successful treatment of acquired myelofibrosis with pure red cell aplasia by cyclosporineQ74527937
Myelodysplastic syndrome with erythroid hypoplasia/aplasia: a case report and review of the literatureQ74842457
Proposals for the classification of the myelodysplastic syndromesQ28275931
Myelodysplastic syndrome: review of the cytogenetic and molecular dataQ30666811
Myelodysplastic syndrome accompanied by i(17) (q10) anomaly following pure red cell aplasia and transient myeloproliferative stageQ33328061
Red cell hypoplasia, thrombocytosis, and leucocytosis: myelodysplastic and proliferative syndromeQ33839608
Pure red cell aplasiaQ34135285
The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restatedQ35912576
The biology of pure red cell aplasiaQ36860063
Red cell aplasia in myelodysplastic syndromeQ37142927
Idiopathic myelofibrosis: historical review, diagnosis and managementQ37363934
Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapyQ40679487
Red cell hypoplasia associated with myeloproliferative and myelodysplastic syndromeQ42843879
Pure red cell aplasia heralding chronic myelomonocytic leukaemiaQ43748025
Pure red cell aplasia associated with chronic myelomonocytic leukaemiaQ58010521
Autoimmune myelodysplasiasQ67797843
Antilymphocyte globulin for myelodysplastic syndromeQ68273237
Transformation of severe aplastic anemia into acute myeloblastic leukemia with monosomy 7Q71114739
The detection of trisomies 8 and 9 in patients with essential thrombocytosis by fluorescence in situ hybridizationQ71864345
Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome. A multiparameter analysis combining conventional cytogenetics, DNA in situ hybridization, and bone marrow culture studiesQ72033642
Cytogenetic clonality in chronic myelomonocytic leukemia studied with fluorescence in situ hybridizationQ72518856
P433issue5
P921main subjectcyclosporineQ367700
P304page(s)514-518
P577publication date2002-06-01
P1433published inInternational Journal of HematologyQ6051416
P1476titlePure red cell aplasia developing into myeloproliferation with myelodysplasia and subsequent leukemia after cyclosporin A therapy
P478volume75

Reverse relations

cites work (P2860)
Q50597195Immunosuppressive treatment in patient with pure red cell aplasia associated with chronic myelomonocytic leukemia: harm or benefit?
Q46653430Pure red cell aplasia and myelofibrosis in B-cell neoplasm
Q33357241Pure red cell aplasia—a rare disease with multiple causes

Search more.